Blood Drops May Help Detect Early-Stage Lung Cancer
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 15, 2021 | Clinical Chemistry, Lung Cancer |
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 10, 2021 | Lung Cancer |
Thermo Fisher’s companion diagnostic test to identify targeted therapies for non-small cell lung cancer patients was granted premarket approval by the FDA.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Lung Cancer |
Biocept’s liquid biopsy-based Target Selector NGS Lung Panel test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC).
Read MorePosted by Chris Wolski | Oct 21, 2021 | Lung Cancer |
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Lung Cancer |
Researchers have developed novel artificial intelligence blood testing technology that detected over 90% of lung cancers from 800 samples.
Read More